Kun Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kun Liu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Fei Quan
College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China
2 shared publications - Shengyuan He
Harbin Medical University College of Bioinformatics Science and Technology Harbin 150081
2 shared publications - Xinxin Zhang
College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China
2 shared publications - Yun Xiao
College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, China
2 shared publications - Bo Pang
College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang 150081, China
1 shared publication - Bo Zhang
Harbin Medical University College of Bioinformatics Science and Technology Harbin 150081
1 shared publication
Latest Publications
- Open Access
- 16 January 2026
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
CancerSEA-X: A Single-cell Resource for Tumor Microenvironment Cell States Across over 30 Cancer Types
Single-cell studies have significantly advanced our understanding of the transcriptional and functional heterogeneity in cancers. Recent studies have identified distinct states of cancer, immune, and stromal cells in the tumor microenvironment (TME), with growing evidence highlighting their clinical significance and therapeutic potential. Here, we present CancerSEA-X, an expanded version of CancerSEA that offers a comprehensive atlas of TME cell states. CancerSEA-X integrates 25 cancer cell states, 105 immune cell states, and 26 stromal cell states from systematically curated publications. Combining 239 single-cell datasets across 32 cancer types, encompassing over 9 million cells from 2120 patients, CancerSEA-X provides functional activity spectra and cancer-specific gene associations for these 156 cell states. These cell state-gene relationships were mapped onto networks, providing a systematic view of the TME. To improve usability, we redesigned the user interface to feature cell state characterization, state-gene correlation analysis, and interactive visualization of cell state-gene networks, enabling researchers to comprehensively explore these states and their functional relevance. Overall, CancerSEA-X serves as a valuable platform for investigating TME cell states, deepening our understanding of cancer heterogeneity, and potentially advancing the design of more effective clinical therapies. CancerSEA-X is freely available at http://biocc.hrbmu.edu.cn/CancerState.
- 16 January 2026
- Published by Oxford University Press (OUP) in Genomics, Proteomics & Bioinformatics
Open AccessCancerSEA-X: A Single-cell Resource for Tumor Microenvironment Cell States Across over 30 Cancer Types
Single-cell studies have significantly advanced our understanding of the transcriptional and functional heterogeneity in cancers. Recent studies have identified distinct states of cancer, immune, and stromal cells in the tumor microenvironment (TME), with growing evidence highlighting their clinical significance and therapeutic potential. Here, we present CancerSEA-X, an expanded version of CancerSEA that offers a comprehensive atlas of TME cell states. CancerSEA-X integrates 25 cancer cell states, 105 immune cell states, and 26 stromal cell states from systematically curated publications. Combining 239 single-cell datasets across 32 cancer types, encompassing over 9 million cells from 2120 patients, CancerSEA-X provides functional activity spectra and cancer-specific gene associations for these 156 cell states. These cell state-gene relationships were mapped onto networks, providing a systematic view of the TME. To improve usability, we redesigned the user interface to feature cell state characterization, state-gene correlation analysis, and interactive visualization of cell state-gene networks, enabling researchers to comprehensively explore these states and their functional relevance. Overall, CancerSEA-X serves as a valuable platform for investigating TME cell states, deepening our understanding of cancer heterogeneity, and potentially advancing the design of more effective clinical therapies. CancerSEA-X is freely available at http://biocc.hrbmu.edu.cn/CancerState.
- 3 August 2023
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- Vol. 11 (9) , 1159-1167
Computational Quantification of Cancer Immunoediting
The remarkable success of cancer immunotherapy has revolutionized cancer treatment, emphasizing the importance of tumor–immune interactions in cancer evolution and treatment. Cancer immunoediting describes the dual effect of tumor–immune interactions: inhibiting tumor growth by destroying tumor cells and facilitating tumor escape by shaping tumor immunogenicity. To better understand tumor–immune interactions, it is critical to develop computational methods to measure the extent of cancer immunoediting. In this review, we provide a comprehensive overview of the computational methods for quantifying cancer immunoediting. We focus on describing the basic ideas, computational processes, advantages, limitations, and influential factors. We also summarize recent advances in quantifying cancer immunoediting studies and highlight future research directions. As the methods for quantifying cancer immunoediting are continuously improved, future research will further help define the role of immunity in tumorigenesis and hopefully provide a basis for the design of new personalized cancer immunotherapy strategies.
- 3 August 2023
- Published by American Association for Cancer Research (AACR) in Cancer Immunology Research
- Vol. 11 (9) , 1159-1167
Computational Quantification of Cancer Immunoediting
The remarkable success of cancer immunotherapy has revolutionized cancer treatment, emphasizing the importance of tumor–immune interactions in cancer evolution and treatment. Cancer immunoediting describes the dual effect of tumor–immune interactions: inhibiting tumor growth by destroying tumor cells and facilitating tumor escape by shaping tumor immunogenicity. To better understand tumor–immune interactions, it is critical to develop computational methods to measure the extent of cancer immunoediting. In this review, we provide a comprehensive overview of the computational methods for quantifying cancer immunoediting. We focus on describing the basic ideas, computational processes, advantages, limitations, and influential factors. We also summarize recent advances in quantifying cancer immunoediting studies and highlight future research directions. As the methods for quantifying cancer immunoediting are continuously improved, future research will further help define the role of immunity in tumorigenesis and hopefully provide a basis for the design of new personalized cancer immunotherapy strategies.